Ozempic
Ozempic, containing the active ingredient semaglutide, is a GLP-1 receptor agonist primarily used for managing type 2 diabetes and aiding in weight loss. It works by enhancing insulin secretion, reducing appetite, and slowing gastric emptying, which can contribute to weight management and potentially improve metabolic health, making it relevant for longevity and health optimization.
Updated 7/14/2026
Semaglutide
compound
Semaglutide is a GLP-1 receptor agonist primarily used for weight management and type 2 diabetes treatment. It works by enhancing insulin secretion, reducing appetite, and slowing gastric emptying, which can lead to significant weight loss. Its role in longevity and health optimization is linked to its potential to improve metabolic health and reduce obesity-related risks.
Updated 7/14/2026
Tirzepatide
compound
Mounjaro, also known as tirzepatide, is a dual GIP and GLP-1 receptor agonist primarily used for weight management and glycemic control. It enhances insulin secretion and reduces appetite, making it a promising compound for obesity and type 2 diabetes management, which are critical factors in longevity and metabolic health.
Updated 7/14/2026